We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Measles Virus Infection Impacts Immune Cells

By LabMedica International staff writers
Posted on 26 Nov 2019
Print article
Image: Colored scanning electron micrograph (SEM) of a B lymphocyte white blood cell (Photo courtesy of the US National Institute of Allergy and Infectious Diseases)
Image: Colored scanning electron micrograph (SEM) of a B lymphocyte white blood cell (Photo courtesy of the US National Institute of Allergy and Infectious Diseases)
Measles is a disease caused by the highly infectious measles virus (MeV) that results in both viremia and lymphopenia. Measles virus is a highly infectious lymphotropic virus associated with an extended period of immunosuppression after resolution of acute viremia.

Lymphocyte counts recover shortly after the disappearance of measles-associated rash, but immunosuppression can persist for months to years after infection, resulting in increased incidence of secondary infections. Memory B cell clones present before infection are depleted in post-measles samples even after lymphocyte counts had recovered, a change not seen in controls given an influenza vaccination.

An international team of scientists led by the Wellcome Sanger Institute (Cambridge, UK) used targeted sequencing to follow blood samples from more than two-dozen children prior to measles infections and again more than a month after the infections cleared. The sequence data pointed to decline in immune memory cells and B lymphocyte white blood cell diversity following measles infections.

In an effort to untangle the specific immune cell changes involved in the process, the team did isotype-resolved B-cell receptor sequencing to barcode and follow immune cells in peripheral blood samples collected at baseline in 26 unvaccinated children from a study in the Netherlands, and again some 40 to 50 days after their measles virus infections. Using B cell receptor (BCR) sequencing of human peripheral blood lymphocytes, the team extrapolated antibody; naïve B cell and memory B lymphocyte profiles; and other immune patterns, comparing them with those in samples from unvaccinated children who dodged measles infections and with samples from adults who received a trivalent inactivated influenza vaccine.

The investigators identified two immunological consequences from measles underlying immunosuppression: (i) incomplete reconstitution of the naïve B cell pool leading to immunological immaturity and (ii) compromised immune memory to previously encountered pathogens due to depletion of previously expanded B memory clones. The team saw decreased antibody levels and poorer B memory immune cell responses to the influenza H1N1 virus in influenza vaccinated ferrets that had been through a measles-like canine distemper virus infection than in the animals that remained canine distemper virus-free.

The authors concluded that their results show that MeV infection causes changes in naïve and memory B lymphocyte diversity that persist after the resolution of clinical disease and thus contribute to compromised immunity to previous infections or vaccinations. This work highlights the importance of MeV vaccination not only for the control of measles but also for the maintenance of herd immunity to other pathogens, which can be compromised after MeV infection. The study was published on November 1, 2019 in the journal Science Immunology.

Related Links:
Wellcome Sanger Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.